Organization Profile

You just read:

TAILORx trial finds 99% of women with low Oncotype DX® Recurrence Score® are free of breast cancer recurrence after five years of hormone therapy alone

News provided by

Genomic Health, Inc.

Sep 28, 2015, 07:30 ET